Is the price fair?
What ROIV's price assumes
- Price / book
- 4.41
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 4.41
- EV / EBIToperating margin −6236%: the multiple describes the denominator
- not meaningful
- Market capitalisation
- $22.6B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
Ranks #77 of 145 by Smart Score